Compare FBRT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRT | OPK |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.7M | 921.2M |
| IPO Year | N/A | 2011 |
| Metric | FBRT | OPK |
|---|---|---|
| Price | $8.66 | $1.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $11.50 | $1.60 |
| AVG Volume (30 Days) | 778.3K | ★ 2.3M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $4.95 | $4.24 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.24 | $0.98 |
| 52 Week High | $11.84 | $1.60 |
| Indicator | FBRT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 82.58 |
| Support Level | $8.64 | $1.25 |
| Resistance Level | $9.26 | $1.52 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 25.15 | 89.41 |
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.